期刊文献+

苯溴马隆治疗高尿酸血症和痛风的疗效观察 被引量:29

Efficacy Observation of Benzbromarone in the Treatment of Hyperuricemia and Gout
暂未订购
导出
摘要 目的:观察苯溴马隆治疗高尿酸血症的疗效。方法:收集我院2011年7月到2013年6月门诊、住院及体检发现高尿酸血症患者116例(其中既往有痛风史患者53例)。将其随机分成观察组(口服苯溴马隆50mg/次,1次/日)和对照组(口服别嘌醇100mg/次,1次/日);对两组患者治疗8周后进行疗效评定。结果:观察组治疗高尿酸血症的疗效明显优于对照组,观察组和对照组的总有效率分别为91.7%和76.8%,两组比较p<0.05,具有统计学意义。结论:苯溴马隆治疗高尿酸血症/痛风疗效可靠,值得临床推广应用。 Objective:To explore the clinical efficacy of Benzbromarone in the treatment of Hyperuricemia and Gout. Methods:116 patients were randomly devided into the observation group and the control group , the observation group were treated with Benzbromarone 50mg,po,qd for 8 weeks,the control group were treated with Allopurinol 100mg, po, qd for 8 weeks.Results:The total effective rate is 91.7%in the observation group and 76.8%in the control group , the clinical efficacy was significantly higher in the observation group than in the control group(P〈0.05).Conclusion:Benzbromarone has satisfactory clinical efficacy in the treatment of Hyperuricemia and Gout,and is worth the promotion and application in the clinical treatment.
作者 宋艳玲
出处 《中国医药导刊》 2014年第5期858-859,共2页 Chinese Journal of Medicinal Guide
关键词 苯溴马隆 高尿酸血症 痛风 别嘌醇 Benzbromarone Hyperuricemia Gout Allopurinol
  • 相关文献

参考文献11

  • 1叶任高,陆再英.内科学[M].第6版.北京:人民卫生出版社,2006:787-788.
  • 2施挂英-关节炎概要[M].第2版.北京:中国医药科技出版社,2005,467-471.
  • 3Ghei M,Mihailescu M,Levison J,et al.Pathogenisis of hyperuricemia:recent advances[J].Curr Rheumatol Rep,2002;(4):270.
  • 4Takahashi S,Yamamoto T, Moriwaki Y, et al.Impaired Lipoprotein metabolism in patients with primary gout: influence of alcohol intake and body weight[J].Br J Rheumatol,1994;(33):731.
  • 5Ruddy S,Harris ED,Sledge CB.Kelley's Textbook of Rheumatology[M].6th ed.Philadelphia:W.B. Saunders,200 1, 1339-1376.
  • 6Verdecchia P, Schillaci G,Reboldi GP, et at.Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: The PIUMA Study[J]. Hypertension,2000;(36): 1072.
  • 7Takahashi S,Moriwaki Y, Tsutsuni Z,et al.lncrease Visceral fat Accumulation further aggravates the risks of insulin resistance in gout[J].Metabolism,2001;(50):393.
  • 8Masseou D,Rotr K,Liu-Bryan R,et al .Overview of hyperuricemia and gout[J].Curt Pharm Des,2005; 11 (32):4117-4124.
  • 9Wortmann RL.Recent advances in the management of goutand hyperuricemia[J]. Curt Opin Rheumatol,2005; 17(3):319324.
  • 10杨藻宸.药理学和药物治疗学[M].第1版.北京:人民卫生出版社,2000:1786-1791.

共引文献710

同被引文献249

引证文献29

二级引证文献172

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部